Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
June 7, 2026Diabetes

1450-P: Differential Regulation of Noncanonical (Deoxy- and Deoxymethyl-) Sphingolipids Biosynthesis in Type 1 and Type 2 Diabetes Mellitus

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLucia CentofantiCMCamillo MoranoMCMichele Dei Cas

Discussion

Loading...

Member takes

Overview

Randomized trial compares deoxy-sphingolipid levels in type 1 and type 2 diabetes, suggesting pathways for lipotoxicity.

Key Points

  • The study aims to compare the levels of deoxy- and deoxymethyl-sphingolipids in type 1 and type 2 diabetes versus healthy individuals.
  • Analyzed sphingolipidomic profiles using targeted LC/MS-MS from plasma samples
  • Included 15 T1D patients, 15 T2D patients, and 15 healthy controls, age-, sex-, and BMI-matched
  • Performed statistical analysis using ANOVA test.
  • Total ceramide concentrations were significantly decreased in T1D (p<0.005)
  • DeoxyCers and deoxyDHCers were elevated in T2D and reduced in T1D compared to both HC (p<0.05) and T2D (p<0.001)
  • No significant differences in sphingosine-1-phosphate levels between groups.

Cite This Study

Centofanti et al. (2026) studied this question.

synapsesocial.com/papers/6a250cbc7def13d035e1ced0https://doi.org/10.2337/db26-1450-p
View Full Paper
Ask AI
Bookmark
Share